Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Protection Of Dexmedetomidine Versus Midazolam In Septic ICU Patients
NCT05903963Phase 1Unknown
- Sponsor
- Minia University
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Minia University. Primary endpoint: Incidence of acute kidney injury at 5 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05903963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903963.